Literature DB >> 35136340

Rosuvastatin-Induced Rhabdomyolysis, Pancreatitis, Transaminitis, and Acute Kidney Injury.

Brent Wagner1,2,3, G Patricia Escobar1,2,3, D Bradley Jackson1,3, Joshua DeAguero1,2.   

Abstract

Changing medications within a drug class requires considering the indication and dosage, possible adverse effects, and drug-drug interactions.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID： 35136340      PMCID： PMC8820201          DOI： 10.12788/fp.0199

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  17 in total

Review 1.  The effects of toxins on muscle.

Authors:  J J Wald
Journal:  Neurol Clin       Date:  2000-08       Impact factor: 3.806

Review 2.  An overview of statin-associated proteinuria.

Authors:  Atul Tiwari
Journal:  Drug Discov Today       Date:  2006-05       Impact factor: 7.851

3.  Rosuvastatin in diabetic hemodialysis patients.

Authors:  Hallvard Holdaas; Ingar Holme; Roland E Schmieder; Alan G Jardine; Faiez Zannad; Gudrun E Norby; Bengt C Fellström
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

4.  Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Authors:  Peter H Jones; Michael H Davidson; Evan A Stein; Harold E Bays; James M McKenney; Elinor Miller; Valerie A Cain; James W Blasetto
Journal:  Am J Cardiol       Date:  2003-07-15       Impact factor: 2.778

Review 5.  Interpretation of the evidence for the efficacy and safety of statin therapy.

Authors:  Rory Collins; Christina Reith; Jonathan Emberson; Jane Armitage; Colin Baigent; Lisa Blackwell; Roger Blumenthal; John Danesh; George Davey Smith; David DeMets; Stephen Evans; Malcolm Law; Stephen MacMahon; Seth Martin; Bruce Neal; Neil Poulter; David Preiss; Paul Ridker; Ian Roberts; Anthony Rodgers; Peter Sandercock; Kenneth Schulz; Peter Sever; John Simes; Liam Smeeth; Nicholas Wald; Salim Yusuf; Richard Peto
Journal:  Lancet       Date:  2016-09-08       Impact factor: 79.321

6.  Human proximal tubular epithelium actively secretes but does not retain rosuvastatin.

Authors:  Anja Verhulst; Rachel Sayer; Marc E De Broe; Patrick C D'Haese; Colin D A Brown
Journal:  Mol Pharmacol       Date:  2008-07-08       Impact factor: 4.436

7.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

Review 8.  Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

Authors:  Albert Selva-O'Callaghan; Marcelo Alvarado-Cardenas; Iago Pinal-Fernández; Ernesto Trallero-Araguás; José Cesar Milisenda; María Ángeles Martínez; Ana Marín; Moisés Labrador-Horrillo; Cándido Juárez; Josep María Grau-Junyent
Journal:  Expert Rev Clin Immunol       Date:  2018-02-23       Impact factor: 4.473

9.  A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.

Authors:  Keith B Hoffman; Christina Kraus; Mo Dimbil; Beatrice A Golomb
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

Review 10.  Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.

Authors:  Erik S Stroes; Paul D Thompson; Alberto Corsini; Georgirene D Vladutiu; Frederick J Raal; Kausik K Ray; Michael Roden; Evan Stein; Lale Tokgözoğlu; Børge G Nordestgaard; Eric Bruckert; Guy De Backer; Ronald M Krauss; Ulrich Laufs; Raul D Santos; Robert A Hegele; G Kees Hovingh; Lawrence A Leiter; Francois Mach; Winfried März; Connie B Newman; Olov Wiklund; Terry A Jacobson; Alberico L Catapano; M John Chapman; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2015-02-18       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.